A 42-year-old woman from Delhi presents with multiple ill-defined erythematous plaques on her trunk and limbs, with moderate sensory loss. Slit-skin smear shows 4–5 acid-fast bacilli per 100 fields. Lepromin test is weakly positive. What is the most appropriate next step in management?

Explanation

## Clinical Classification and Management Strategy **Key Point:** This patient has **Borderline Lepromatous (BL) or Lepromatous Leprosy (LL)**, classified as **Multibacillary (MB) leprosy**, based on: - Multiple ill-defined lesions - Moderate sensory loss (not as marked as in TT) - **4–5 bacilli per 100 fields** (bacillary load ≥2 = MB) - Weakly positive or negative lepromin test (poor cell-mediated immunity) ### Bacillary Load Classification | Bacillary Count | Classification | Lepromin Test | MDT Regimen | |-----------------|----------------|---------------|-------------| | 0–1 per 100 fields | Paucibacillary (PB) | Positive | 6 months | | ≥2 per 100 fields | Multibacillary (MB) | Negative/weak | 12 months | **High-Yield:** The **slit-skin smear bacillary index (BI)** is the gold standard for classifying leprosy as PB vs. MB. A count of 4–5 bacilli unequivocally indicates MB disease. ### Why 12-Month MDT with Clofazimine? **Clinical Pearl:** Multibacillary leprosy requires: 1. **Longer treatment duration** (12 months) to eliminate higher bacillary burden 2. **Three-drug regimen** (rifampicin + dapsone + clofazimine) to prevent drug resistance 3. **Baseline nerve function assessment** before starting treatment (mandatory in all leprosy) ### Management Flowchart ```mermaid flowchart TD A[Multiple lesions + moderate sensory loss]:::outcome --> B{Slit-skin smear bacilli count?}:::decision B -->|0-1 per 100 fields| C[Paucibacillary]:::outcome C --> D[6-month MDT: Rifampicin + Dapsone]:::action B -->|≥2 per 100 fields| E[Multibacillary]:::outcome E --> F[Baseline nerve function assessment]:::action F --> G[12-month MDT: Rifampicin + Dapsone + Clofazimine]:::action G --> H[Monitor for lepra reactions]:::action ``` **Mnemonic:** **MB = More Bacilli = More Months + More Medicines** — Multibacillary disease requires 12 months of three-drug therapy.